Align has stronger clinical trial backing than most over-the-counter probiotics, but the evidence is modest and the benefits are narrower than its marketing suggests. Its active ingredient, the bacterial strain Bifidobacterium longum subsp. infantis 35624, has been tested in randomized controlled trials primarily for irritable bowel syndrome, with statistically significant but small improvements in abdominal pain. Whether that makes it “good” depends on what you expect a probiotic to do and whether your specific symptoms match the conditions it has actually been studied for.
What Is Actually Inside Align
Align’s active ingredient is a single bacterial strain: Bifidobacterium infantis 35624, sometimes labeled as B. longum subsp. infantis 35624 after a taxonomic reclassification of the Bifidobacterium family.1PubMed. Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth Unlike many competing products that pack in multiple strains and advertise high colony-forming unit (CFU) counts in the tens of billions, Align contains roughly one billion CFU of this single strain per capsule. Independent lab testing has confirmed the product actually delivers what the label claims: a tested sample contained about 1.8 billion CFU per dose, slightly exceeding the stated one billion.2PubMed Central. Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment That consistency matters because many probiotic brands fail third-party testing and contain fewer live organisms than advertised.
The single-strain approach is deliberate. B. infantis 35624 was originally isolated from human intestinal tissue and developed for clinical use. Procter & Gamble (which manufactures Align) invested in clinical trials specifically using this strain, which means the evidence base is tied to this exact organism rather than to the broader Bifidobacterium family.
The Evidence for IBS Symptom Relief
Most of the clinical evidence behind Align comes from trials in people with irritable bowel syndrome. In one of the key studies, a double-blind randomized controlled trial in 362 women meeting diagnostic criteria for IBS, the group receiving B. infantis 35624 at one hundred million CFU daily saw a reduction in abdominal pain scores compared to placebo. The difference was statistically significant but not dramatic in absolute terms.3PubMed Central. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide A gastroenterology review summarizing the clinical data noted that two trials of B. infantis 35624 found significant reductions in pain, bloating, and bowel movement difficulty compared to placebo, with the follow-up study also showing greater global relief of IBS symptoms.4PubMed Central. A Gastroenterologist’s Guide to Probiotics
That said, professional gastroenterology guidelines are lukewarm. The American Gastroenterological Association’s 2020 technical review examined the evidence for probiotics across gastrointestinal conditions and did not make strong endorsements for specific probiotic strains in adults with IBS. The AGA noted that guidelines from multiple professional societies support probiotics for otherwise healthy children with acute gastroenteritis, but the adult IBS evidence was treated with more caution.5PubMed Central. AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders The gap between what a supplement company can say about its product and what a medical society will formally recommend is wide in the probiotic space, and Align sits squarely in that gap.
How Align Stacks Up Against Other Probiotic Strains
One of the more useful pieces of recent research is a large network meta-analysis that pooled data from 81 randomized controlled trials covering over 9,200 participants with IBS. This kind of analysis lets researchers rank different strains against each other rather than just comparing each one against placebo. B. infantis 35624 was among the strains that performed better than placebo, but it did not top the rankings. Lactobacillus acidophilus DDS-1 ranked first for improving overall IBS symptom severity. For abdominal pain specifically, Bacillus coagulans strains came out ahead.6PubMed Central. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
This doesn’t mean Align is ineffective, but it does mean it probably isn’t the best-performing option if you’re choosing purely based on the trial data. The probiotic market is flooded with products that have zero clinical trials behind them, so Align still sits well above average in terms of evidence. But if you’re shopping by the data, there are strains with stronger performance in the same meta-analyses. The practical challenge is that many of those top-ranked strains are harder to find as standalone consumer products.
A Stomach Acid Problem
Here’s a finding that Align’s marketing doesn’t highlight. When researchers tested a wide range of commercial probiotic products for their ability to survive simulated stomach acid conditions, Align’s bacteria died off rapidly. Viability dropped significantly within the first 30 minutes of exposure to fluid at a pH of 1.5 (roughly the acidity of a fasting stomach), and no residual living cells were detected at later time points.2PubMed Central. Analysis of the microbial content of probiotic products commercialized worldwide and survivability in conditions mimicking the human gut environment By definition, probiotics should survive gastric acid and bile to reach the small intestine and colon where they can exert their effects.4PubMed Central. A Gastroenterologist’s Guide to Probiotics
This raises an obvious question: if most of the bacteria die in your stomach, how did the clinical trials show any benefit at all? A few explanations are plausible. Stomach pH varies depending on whether you’ve eaten recently, and it’s considerably less acidic after a meal, which would allow more bacteria to survive transit. It’s also possible that even dead or dying bacteria release components that interact with the immune system in the gut. Some probiotic researchers argue that the metabolites and cell wall fragments themselves trigger beneficial responses, so complete survival may not be strictly necessary. Still, the lab data on acid survival is something to keep in mind, particularly if you’re taking Align on an empty stomach.
Side Effects and the Methane Question
Align is generally well tolerated. Most people report no side effects, and the clinical trials haven’t flagged serious adverse events in healthy adults. But there’s a subtler effect worth knowing about. A small study that measured breath gas levels before and during Align use found that methane levels were significantly higher during the probiotic period. The proportion of participants with elevated methane readings nearly doubled, going from three out of 19 subjects before probiotic use to six out of 19 during use.7Springer. Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth
Methane production in the gut is associated with slower intestinal transit, and elevated methane on a breath test is sometimes used as a marker for conditions like small intestinal bacterial overgrowth. If you already tend toward constipation, this is worth noting. The increase was statistically significant, even in a small group. Whether this translates to noticeable constipation symptoms in most users isn’t clear, but it’s an example of how a probiotic intended to improve gut function can shift the microbial landscape in ways that aren’t always straightforward.
The more common and mild side effects people report anecdotally with Align, like temporary bloating or gas in the first few days of use, are typical of most probiotics and usually settle within a week or two as the gut adjusts.
It Won’t Permanently Reshape Your Gut
A common misconception about probiotics is that taking them for a while will permanently shift your gut microbiome into a healthier configuration. The evidence says otherwise. Many probiotic strains, including those in the Bifidobacterium family, do not colonize the gut long-term. They can be detected in stool during active consumption, but most strains are no longer recoverable one to four weeks after you stop taking them.4PubMed Central. A Gastroenterologist’s Guide to Probiotics A pilot study tracking probiotic persistence found that tested strains appeared in feces roughly one to two days after first intake and typically washed out within about three to six days after stopping, with occasional individuals retaining certain strains longer.8PubMed Central. Total Transit Time and Probiotic Persistence in Healthy Adults: A Pilot Study
This means Align, like most probiotics, is something you’d need to take continuously to maintain whatever benefit it provides. If it’s helping your IBS symptoms, stopping will likely mean the symptoms return within a few weeks. That’s a meaningful consideration for cost, since Align typically runs between $25 and $40 per month depending on the retailer and package size, and it’s rarely covered by insurance since it’s a supplement rather than a prescription medication.
How Probiotics Like Align Might Actually Work
The mechanisms by which B. infantis 35624 affects gut symptoms aren’t fully worked out, but the research points in a few directions. Certain Bifidobacterium strains have been shown to strengthen the intestinal barrier by increasing the production of proteins that hold gut lining cells together. This involves the upregulation of what are called tight junction proteins, and the effect has been demonstrated in cell cultures, animal models, and some clinical settings.9PubMed Central. Probiotics and the intestinal tight junction barrier function A leakier gut lining allows more inflammatory molecules to pass through, so tightening those junctions could reduce the low-grade inflammation thought to contribute to IBS symptoms.
There’s also an immune-modulation angle. Probiotic bacteria, including lactic acid bacteria and Bifidobacterium species, participate in regulating inflammatory responses in the gut. A key part of this involves boosting the anti-inflammatory signaling molecule IL-10, which helps calm overactive immune responses in the intestinal lining.10PubMed Central. Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases Animal studies using B. infantis 35624 specifically have shown it can reduce inflammatory markers and protect against tissue damage during intestinal infections.11PubMed Central. Impact of Bifidobacterium longum Subspecies infantis on Pediatric Gut Health and Nutrition: Current Evidence and Future Directions These effects are genuinely interesting, but it’s worth noting that much of the mechanistic work has been done in animals or cell cultures, and the leap to meaningful clinical impact in humans is always uncertain.
The Placebo Factor in IBS Probiotic Trials
IBS is a condition where placebo responses are famously large. When you’re studying something like abdominal pain and bloating, which are subjective and fluctuate naturally, the simple act of participating in a trial and believing you might be receiving treatment can produce measurable improvement. Research on placebo effects in gastrointestinal studies has shown that people with milder symptoms at baseline tend to have more pronounced placebo responses, which can wash out real treatment effects.12Scientific Reports. An eight-week placebo-controlled RCT on the efficacy of a probiotic nutritional intervention for subclinical gastrointestinal symptoms in students
This doesn’t mean Align’s trial results are fake. The trials were placebo-controlled, so the improvements attributed to B. infantis 35624 were measured against the placebo group. But the overall size of the benefit above placebo was small, which means a fair amount of the improvement that individual users experience might be attributable to expectation rather than the bacteria themselves. If Align makes you feel better and you don’t mind the cost, that feeling is real regardless of the mechanism. But if you’re trying to decide whether the bacteria are doing something your gut couldn’t do on its own, the honest answer is that the effect size is modest.
Who Should Be Cautious
For healthy adults, Align carries minimal risk. The side effect profile in clinical trials is comparable to placebo, and the strain has a long track record of commercial use. But the safety picture changes for people with compromised immune systems. Case reports and reviews have documented serious infections, including bloodstream infections, endocarditis, liver abscesses, and fungemia, caused by probiotic organisms in high-risk patients.13PubMed Central. Probiotics: Should All Patients Take Them? One case report described recurrent Lactobacillus bacteremia in an immunocompromised patient with a history of probiotic use, with the infection proving resistant to antibiotic therapy and ultimately fatal.14PubMed Central. Recurrent Lactobacillus Rhamnoses Bacteremia and Complications in an Immunocompromised Patient With History of Probiotic Use: A Case Report
That case involved a Lactobacillus species rather than Bifidobacterium, but the broader point applies: introducing live bacteria into the body of someone whose immune system can’t keep them in check carries real risk. If you’re undergoing chemotherapy, taking immunosuppressive drugs after an organ transplant, or living with advanced HIV, you should talk to your doctor before starting any probiotic, including Align.
What Align Doesn’t Do
Align is marketed with broad language about “digestive health” and “natural digestive balance,” but the clinical evidence is really about a narrow set of IBS symptoms. There’s no strong human trial data showing B. infantis 35624 prevents common colds, improves mood, clears skin conditions, helps with weight loss, or does any of the other things the general probiotic conversation has absorbed from preliminary or unrelated research. The strain-specific nature of probiotic effects is one of the most consistent findings in the field: what works for one strain does not automatically apply to another, and what works for one condition may not help with a different one.9PubMed Central. Probiotics and the intestinal tight junction barrier function
This is the gap that catches most consumers. You hear that “probiotics are good for you,” and the logical next step seems like buying any well-reviewed product and expecting broad benefits. But the research doesn’t support that kind of generalization. Align’s evidence applies to IBS-related abdominal pain, bloating, and bowel difficulty in the specific populations studied. If your interest is traveler’s diarrhea prevention, antibiotic-associated diarrhea, or inflammatory bowel disease, the strains with the best evidence are different ones.
Practical Advice for Trying Align
If you decide to try Align for IBS symptoms, a few practical points can help you get the most accurate sense of whether it works for you. Take it with food rather than on an empty stomach, since the less acidic post-meal environment gives the bacteria a better chance of surviving stomach acid. Give it at least four weeks before deciding it isn’t working, since that’s the typical trial duration in the studies that showed benefit. And keep your expectations calibrated: the difference between Align and placebo in trials was real but small, so you’re looking for a modest improvement in symptoms, not a dramatic transformation.
Storage also matters more than people realize. Align uses a patented delivery system and is sold in blister packs intended to protect the bacteria from moisture and heat, which is an advantage over products sold in open bottles. But all probiotics lose viability over time, especially at higher temperatures. Keeping the product at room temperature is fine per the label, but storing it somewhere consistently cool will help preserve the bacteria closer to their original count through the end of the package.